Jeffrey Levy, DO
Foot and Ankle Surgery · Newport News, VANPI 1720040306
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (54.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 63.0% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2020 at $10,047 and has fallen 98.0% since, to $203 in 2025.
Across 74 payments — averaging $249.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$12K
- Stryker$3K
- Fortis Surgical, LLC$2K
- Orthofix Medical, Inc.$1K
- Bioventus LLC$124
- Nevro Corp.$97
- plus $772 from 20 others
What the payments were for
- Speaking & faculty fees$290%
- Grants$10,00054%
- Travel & lodging$3,28818%
- Food & beverage$2,76715%
- Education$2,40013%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 6 | $11,639 |
| Stryker | 17 | $2,539 |
| Fortis Surgical, LLC | 10 | $1,885 |
| Orthofix Medical, Inc. | 7 | $1,427 |
| Bioventus LLC | 5 | $124 |
| Nevro Corp. | 1 | $97 |
| Medical Device Business Services, Inc. | 2 | $93 |
| Amgen | 4 | $83 |
| Novastep Inc. | 1 | $71 |
| Trilliant Surgical LLC. | 1 | $69 |
| UCB, Inc. | 3 | $60 |
| Medline Industries LP | 1 | $58 |
| Johnson & Johnson | 1 | $56 |
| Restor3d, Inc. | 1 | $51 |
| Paragon 28, Inc. | 1 | $38 |
| Sanofi | 2 | $33 |
| Acorda Therapeutics, Inc | 2 | $29 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Abbott | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
| Fidia Pharma USA Inc. | 1 | $13 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
| Collegium Pharmaceutical, Inc. | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TL-HEX TRUELOK HEXAPOD SYSTEM$1,427
- INFINITY$1,161
- PROPHECY$950
- AUGMENT INJECTABLE$161
- DISTAL EXTREMITIES INSTRUMENTS FOOT & ANKLE DYNANITE$113
How this compares
$18,484 in reported general payments places this provider in the 85th percentile of 260 foot and ankle surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 48 | $379 |
| Diclofenac Sodium | 16 | $251 |
| Ondansetron Hcl | 47 | $211 |
| Meloxicam | 75 | $208 |
| Oxycodone Hcl | 44 | $198 |
| Methylprednisolone | 16 | $89 |
| Cephalexin | 41 | $76 |
| Clindamycin Hcl | 11 | $12 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Newport News
- Bryanna VeselyNewport News$16K
- Michael BrassellNewport News$15K
- Mark JonesNorth Chesterfield$2.4M
- Oliver SchipperArlington$1.2M
- Steven NeufeldFalls Church$857K
- Charles ZelenRoanoke$363K
- Ryan VazalesGlen Allen$337K
- Jugal DhariaFairfax$309K
- William SimonVirginia Beach$292K
- William GrantVirginia Beach$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.